CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,000 | +25.9% | 7,768 | +54.8% | 0.00% | – |
| Q2 2023 | $170,000 | +80.9% | 5,019 | +92.2% | 0.00% | – |
| Q1 2023 | $94,000 | -60.8% | 2,612 | -51.5% | 0.00% | – |
| Q4 2022 | $240,000 | +1311.8% | 5,381 | +807.4% | 0.00% | – |
| Q3 2022 | $17,000 | +112.5% | 593 | +96.4% | 0.00% | – |
| Q2 2022 | $8,000 | -91.7% | 302 | -89.3% | 0.00% | – |
| Q1 2022 | $96,000 | -73.9% | 2,829 | -70.4% | 0.00% | – |
| Q4 2021 | $368,000 | +31.4% | 9,544 | +84.0% | 0.00% | – |
| Q3 2021 | $280,000 | +211.1% | 5,187 | +93.3% | 0.00% | – |
| Q2 2021 | $90,000 | +2150.0% | 2,684 | +995.5% | 0.00% | – |
| Q4 2020 | $4,000 | – | 245 | +1784.6% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 13 | -95.2% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 272 | -80.9% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 1,427 | +194.2% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 485 | -14.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 569 | +4276.9% | 0.00% | – |
| Q2 2019 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |